和邦生物 (603077.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(和邦生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,965,251,679.742,849,179,316.781,999,261,196.402,389,645,532.882,343,848,975.121,696,145,128.982,394,468,174.84
 营业收入(元) 1,965,251,679.742,849,179,316.781,999,261,196.402,389,645,532.882,343,848,975.121,696,145,128.982,394,468,174.84
二、营业总成本(元) 1,945,826,220.102,659,883,077.861,944,326,999.842,064,607,233.181,892,092,060.671,451,528,331.841,917,401,447.52
 营业成本(元) 1,777,755,934.082,509,772,631.541,797,137,427.201,885,002,711.181,761,637,302.021,355,437,250.931,769,492,414.83
 研发费用(元) 7,725,304.416,447,236.108,346,347.4818,703,894.5710,534,511.669,000,163.219,108,322.93
 营业税金及附加(元) 13,249,939.0426,962,270.6911,658,160.0022,869,675.0614,248,472.5515,241,462.4913,891,280.65
 销售费用(元) 20,985,121.9816,846,770.7316,371,720.9118,496,565.3513,779,675.1113,426,692.0613,859,454.24
 管理费用(元) 109,028,158.1889,079,393.14106,560,740.12144,941,611.1894,960,038.5067,339,723.95106,161,061.05
 财务费用(元) 17,081,762.4110,774,775.664,252,604.13-25,407,224.16-3,067,939.17-8,916,960.804,888,913.82
  其中:利息费用(元) 23,340,744.4020,828,405.4416,275,155.93-17,701,567.6214,944,868.7212,854,083.8414,275,437.52
  其中:利息收入(元) 12,235,243.048,852,863.939,143,232.9116,787,291.6915,860,155.9316,914,555.2410,789,441.25
 资产减值损失(元) -2,604,432.71------
 信用减值损失(元) -3,400,377.478,606,882.85-14,527,656.528,166,559.03-10,038,635.62-2,543,860.85-9,040,151.94
三、其他经营收益
 加:投资收益(元) -958,421.41435,451.27-735,649.1229,113,529.273,720,136.2435,973,360.286,412,117.15
  其中:对联营企业和合营企业的投资收益(元) ---5,905,257.515,409,827.8936,023,160.363,884,758.15
 资产处置收益(元) 12,545.9710,528.03-46,772.10-80,953.54884,645.931,398.073,091.77
 其他收益(元) 2,057,666.657,733,032.673,988,080.035,704,056.166,347,868.462,677,850.332,764,429.74
四、营业利润(元) 14,532,440.67202,155,099.5543,612,198.85331,189,427.67481,053,407.28252,343,067.15477,206,214.04
 加:营业外收入(元) 27,884.2212.734.633,215,475.906.8625.649.24
 减:营业外支出(元) 379,743.31442,837.183,601.468,278,231.9650,417.1191,059.79622,403.93
五、利润总额(元) 14,180,581.58201,712,275.1043,608,602.02326,126,671.61481,002,997.03252,252,033.00476,583,819.35
 减:所得税费用(元) 6,691,962.0940,807,126.3016,465,391.2761,502,844.1070,069,459.0230,570,761.7995,123,195.45
六、净利润(元) 7,488,619.49160,905,148.8027,143,210.75264,623,827.51410,933,538.01221,681,271.21381,460,623.90
(一)按经营持续性分类
  持续经营净利润(元) 7,488,619.49160,905,148.8027,143,210.75264,623,827.51410,933,538.01221,681,271.21381,460,623.90
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 29,048,798.43162,477,258.5029,792,564.09264,199,528.90402,512,640.68219,970,533.01396,561,190.75
  少数股东损益(元) -21,560,178.94-1,572,109.70-2,649,353.34424,298.618,420,897.331,710,738.20-15,100,566.85
 扣除非经常性损益后的净利润(元) 28,338,421.57158,920,141.9828,084,784.36244,961,511.44397,621,034.56196,466,371.78396,418,118.88
七、每股收益
 一、基本每股收益(元) -0.02-0.030.050.030.05
 二、稀释每股收益(元) -0.02-0.030.050.030.05
八、其他综合收益(元) -16,710,311.29-17,854,761.741,488,590.7431,748,983.62-14,136,424.8625,306,987.30-11,232,306.62
 归属于母公司股东的其他综合收益(元) -15,123,622.39-17,841,597.361,311,974.7934,817,094.91-13,233,409.0417,121,462.47-9,740,716.80
 归属于少数股东的其他综合收益(元) -1,586,688.90-13,164.38176,615.95-3,068,111.29-903,015.828,185,524.83-1,491,589.82
九、综合收益总额(元) -9,221,691.80143,050,387.0628,631,801.49296,372,811.13396,797,113.15246,988,258.51370,228,317.28
 归属于母公司所有者的综合收益总额(元) 13,925,176.04144,635,661.1431,104,538.88299,016,623.81389,279,231.64237,091,995.48386,820,473.95
 归属于少数股东的综合收益总额(元) -23,146,867.84-1,585,274.08-2,472,737.39-2,643,812.687,517,881.519,896,263.03-16,592,156.67
公告日期 2024-10-312024-08-302024-04-202024-04-202023-10-212023-08-302023-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院